These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 25997494)
61. Matrix metalloproteinases (MMPs) in health and disease: an overview. Malemud CJ Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548 [TBL] [Abstract][Full Text] [Related]
62. [The role of selected matrix metalloproteinases and their inhibitors in colorectal cancer development]. Groblewska M; Mroczko B; Szmitkowski M Postepy Hig Med Dosw (Online); 2010 Jan; 64():22-30. PubMed ID: 20173217 [TBL] [Abstract][Full Text] [Related]
63. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Rosenberg GA; Dencoff JE; Correa N; Reiners M; Ford CC Neurology; 1996 Jun; 46(6):1626-32. PubMed ID: 8649561 [TBL] [Abstract][Full Text] [Related]
64. Staphylococcus aureus on the effect of expression of MMPs/TIMPs and uPA system in bovine mammary fibroblasts. Miao Z; Ding Y; Bi Y; Chen M; Cao X; Wang F J Microbiol Immunol Infect; 2021 Jun; 54(3):411-419. PubMed ID: 31734109 [TBL] [Abstract][Full Text] [Related]
65. [The role of metalloproteinases and their inhibitors in pancreatic cancer]. Łukaszewicz M; Mroczko B; Szmitkowski M Postepy Hig Med Dosw (Online); 2008 Apr; 62():141-7. PubMed ID: 18414340 [TBL] [Abstract][Full Text] [Related]
66. Modulation of human renal cell carcinoma 786-0 MMP-2 and MMP-9 activity by inhibitors and inducers in vitro. Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M Med Oncol; 2006; 23(2):245-50. PubMed ID: 16720925 [TBL] [Abstract][Full Text] [Related]
67. Dysregulation of matrix metalloproteinases and their tissue inhibitors is related to abnormality of left ventricular geometry and function in streptozotocin-induced diabetic minipigs. Lu L; Zhang Q; Pu LJ; Peng WH; Yan XX; Wang LJ; Chen QJ; Zhu ZB; Michel JB; Shen WF Int J Exp Pathol; 2008 Apr; 89(2):125-37. PubMed ID: 18336530 [TBL] [Abstract][Full Text] [Related]
68. Urokinase directly activates matrix metalloproteinases-9: a potential role in glioblastoma invasion. Zhao Y; Lyons CE; Xiao A; Templeton DJ; Sang QA; Brew K; Hussaini IM Biochem Biophys Res Commun; 2008 May; 369(4):1215-20. PubMed ID: 18355442 [TBL] [Abstract][Full Text] [Related]
69. [Matrix metalloproteinases and their endogenous regulators in squamous cervical carcinoma (review of the own data)]. Solovуeva NI; Timoshenko OS; Gureeva TA; Kugaevskaya EV Biomed Khim; 2015; 61(6):694-704. PubMed ID: 26716740 [TBL] [Abstract][Full Text] [Related]
70. Antitumor effect of a combination of lysine, proline, arginine, ascorbic acid, and green tea extract on pancreatic cancer cell line MIA PaCa-2. Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M Int J Gastrointest Cancer; 2005; 35(2):97-102. PubMed ID: 15879623 [TBL] [Abstract][Full Text] [Related]
71. Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival. Jones LE; Humphreys MJ; Campbell F; Neoptolemos JP; Boyd MT Clin Cancer Res; 2004 Apr; 10(8):2832-45. PubMed ID: 15102692 [TBL] [Abstract][Full Text] [Related]
72. Modulation of MMP-2 and -9 secretion by cytokines, inducers and inhibitors in human melanoma A-2058 cells. Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M Oncol Rep; 2017 Jun; 37(6):3681-3687. PubMed ID: 28440509 [TBL] [Abstract][Full Text] [Related]
73. Amiloride modulates urokinase gene expression at both transcription and post-transcription levels in human colon cancer cells. Wang Y; Dang J; Liang X; Doe WF Clin Exp Metastasis; 1995 May; 13(3):196-202. PubMed ID: 7750207 [TBL] [Abstract][Full Text] [Related]
74. The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer. Herszényi L; Hritz I; Lakatos G; Varga MZ; Tulassay Z Int J Mol Sci; 2012 Oct; 13(10):13240-63. PubMed ID: 23202950 [TBL] [Abstract][Full Text] [Related]
75. Epidermal growth factor promotes invasiveness of pancreatic cancer cells through NF-kappaB-mediated proteinase productions. Zhang H; Ma G; Dong M; Zhao M; Shen X; Ma Z; Guo K Pancreas; 2006 Jan; 32(1):101-9. PubMed ID: 16340751 [TBL] [Abstract][Full Text] [Related]
76. Transforming growth factor-β, matrix metalloproteinases, and urokinase-type plasminogen activator interaction in the cancer epithelial to mesenchymal transition. Santibanez JF; Obradović H; Kukolj T; Krstić J Dev Dyn; 2018 Mar; 247(3):382-395. PubMed ID: 28722327 [TBL] [Abstract][Full Text] [Related]
77. Effect of the expression of matrix metalloproteases and their tissue inhibitors on survival of patients with resectable colorectal cancer. González L; Eiró N; González LO; Andicoechea A; Barbón E; García-Muñiz JL; Vizoso FJ Dig Dis Sci; 2012 Aug; 57(8):2063-71. PubMed ID: 22488635 [TBL] [Abstract][Full Text] [Related]
78. In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors. Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A Int J Oncol; 2014 Jan; 44(1):27-34. PubMed ID: 24190483 [TBL] [Abstract][Full Text] [Related]
79. Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials. Bloomston M; Zervos EE; Rosemurgy AS Ann Surg Oncol; 2002 Aug; 9(7):668-74. PubMed ID: 12167581 [TBL] [Abstract][Full Text] [Related]
80. Expression and localization of mRNAs for matrix metalloproteinases and their inhibitors in mixed bronchioloalveolar carcinomas with invasive components. Kanomata N; Nakahara R; Oda T; Aoyagi Y; Ishii G; Yokose T; Hasebe T; Nagai K; Yokozaki H; Ochiai A Mod Pathol; 2005 Jun; 18(6):828-37. PubMed ID: 15696122 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]